Co-evolution of physical and social technologies in clinical practice: The case of HIV treatments

Research Policy

Volumn 36, Issue 7, 2007, Pages 1070-1087

  Merito, Monica ^a   Bonaccorsi, Andrea ^b  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

HIV AIDS; Medical innovation; Sequence analysis; Social technologies

Indexed keywords

INNOVATION; TECHNOLOGY TRANSFER;

MEDICAL INNOVATION; SEQUENCE ANALYSIS; SOCIAL TECHNOLOGIES;

PATIENT TREATMENT;

EID: 34548393610     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2007.04.005     Document Type: Article

References (52)

1. Abbott A. Sequence analysis: new methods for old ideas. Annual Review of Sociology 21 (1995) 93-113
2. Abbott A., and Hrycak A. Measuring resemblance in sequence data. An optimal matching analysis of musicians' careers. American Journal of Sociology 96 (1990) 144-185
3. Andrews E.J., and Redmond H.P. A review of clinical guidelines. British Journal of Surgery 8 (2004) 956-964
4. Arrow K.J. Uncertainty and the welfare economics of medical care. American Economic Review 53 (1963) 941-973
5. Blume S. Cochlear implantation: establishing a clinical feasibility, 1957-1982. In: Rosenberg N., et al. (Ed). Sources of Medical Technology: Universities and Industry (1995), National Academy Press, Washington
6. Bonaccorsi A., and Thoma G. Institutional Complementarity and Inventive Performance in Nano Science and Technology. Research Policy 36 (2007) 813-831
7. British HIV Association, 1997-2005. HIV Treatment Guidelines. Available at: http://www.bhiva.org/.
8. Burt R.S. Social contagion and innovation: cohesion versus structural equivalence. American Journal of Sociology 92 (1987) 1287-1335
9. Christopherson C., Lu S.D., and Kwok S. Laboratory markers of antiviral activity. Antiviral Therapy 3 (1998) 247-250
10. Coleman J.S., Katz E., and Menzel H. Medical Innovation: A Diffusion Study (1966), Bobbs-Merrill, Indianapolis
11. Di Maggio P.J., and Powell W.W. The iron cage revisited: institutional isomorphism and collective rationality in organizational fields. American Sociological Review 48 (1983) 147-160
12. Egger M., Hirschel B., Francioli P., et al. Impact of new antiretrovirals combination therapies in HIV infected patients in Switzerland: prospective multicentre study. British Medical Journal 315 (1997) 1194-1199
13. European AIDS Clinical Society, 2001-2005. European Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe. Available at: http://www.eacs.eu/guide/index.htm.
14. Foray D., and Hargreaves D. The development of knowledge of different sectors: a model and some hypotheses. London Review of Education 1 (2003) 7-19
15. Forrest J., and Abbott A. The optimal matching method for anthropological data. Journal of Quantitative Anthropology 2 (1990) 151-170
16. Fuchs V.R. Health care and the united states economic system: an essay in abnormal physiology. Milbank Memorial Fund Quarterly 50 (1972) 211-237
17. Gelijns A.C., and Rosenberg N. The dynamics of technological change in medicine. Health Affairs 13 (1994) 28-46
18. Gelijns A.C., and Rosenberg N. The changing nature of technology development. In: Gelijns A.C., and Rosenberg N. (Eds). Sources of Medical Technology: Universities and Industry (1995), National Academy Press, Washington
19. Gelijns A.C., Rosenberg N., and Moskowitz A.J. Capturing the unexpected benefits of medical research. New England Journal of Medicine 339 (1998) 693-698
20. Gelijns A.C., Graff Zivin J., and Nelson R.R. Uncertainty and technological change in medicine. Journal of Health Politics, Policy and Law 26 (2001) 913-924
21. Greer A.L. Medical technology: assessment, adoption, and utilization. A review of the literature. Journal of Medical Systems 5 (1981) 129-145
22. Greer A.L. The state of the art versus the state of the science. The diffusion of new medical technologies into practice. International Journal of Technology Assessment in Health Care 4 (1988) 5-26
23. Gusfield D. Algorithms on Strings, Trees, and Sequences, Computer Science and Computational Biology (1993), Cambridge University Press
24. Hammer S.M., Squires K.E., Hughes M.D., et al. A controlled trial of two nucleoside analogues plus Indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. New England Journal of Medicine 337 (1997) 725-733
25. Hirshleifer J. The private and social value of information and the reward to inventive activity. American Economic Review 61 (1971) 561-574
26. International AIDS Society-USA Panel, 1998-2006. Treatment Guidelines. Available at: http://www.iasusa.org/pub/index.html.
27. Italian Ministry of Health, 1998-2005. Aggiornamento sulla terapia antiretrovirale. Available at: http://www.ministerosalute.it/aids/aids.jsp.
28. Kaufman L., and Rousseeuw P.J. Finding Groups in Data. An Introduction to Cluster Analysis (1990), Wiley-Interscience Publication, New York
29. Langlois R.N., and Savage D.A. Standards, modularity and innovation: the case of medical practice. In: Garud R., and Karnøe P. (Eds). Path Dependence and Path Creation (2001), Lawrence Erlbaum, Hillsdale 149-168
30. Maguire S. Discourse and adoption of innovations: a study of HIV/AIDS treatments. Health Care Management Review 27 (2002) 74-88
31. Merito M., Bonaccorsi A., Pammolli F., et al. Economic evaluation of HIV treatments: The I.CO.N.A. cohort study. Health Policy 74 (2005) 304-313
32. Metcalfe J.S., James A., and Mina A. Emergent innovation systems and the delivery of clinical services: the case of intra-ocular lenses. Research Policy 34 (2005) 1283-1304
33. Meyer A.D., and Goes J.B. Organizational assimilation of innovations: a multilevel contextual analysis. Academy of Management Journal 31 (1988) 897-923
34. Mocroft A., Ledergerber B., Katlama C., et al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362 (2003) 22-29
35. Montaner J.S.G., Reiss P., Cooper D., et al. A randomised, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients the INCAS trial. Journal of the American Medical Association 279 (1998) 930-937
36. Needleman S., and Wunsch C. A general method applicable to the search for similarities in the amino acid sequence of two proteins. Journal of Molecular Biology 48 (1970) 443-453
37. Nelson R.R. In: Fuchs V.R. (Ed). Issues and Suggestions for the Study of Industrial Organizations in a Regime of Rapid Technical Change. Policy Issues Research Opportunities in Industrial Organization (1972), Columbia University Press, New York
38. Nelson R.R., and Sampat B. Making sense of institutions as a factor shaping economic performance. Journal of Economic Behavior and Organization 44 (2001) 31-54
39. Nelson R.R. Technology, Institutions, and Economic Growth (2005), Harvard University Press, Cambridge
40. Palella Jr. F.J., Delaney K.M., Moorman A.C., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 338 (1998) 853-860
41. Rogers E.M. The Diffusion of Innovations (1995), Free Press, New York
42. Sankoff D., and Kruskal J.B. Time Warps, String Edits, and Macromolecules (1983), Addison-Wesley, Reading, MA
43. Shi M., Taylor J.M., Currier R.J., et al. Replacing time since human immunodeficiency virus infection by marker values in predicting residual time to acquired immunodeficiency syndrome diagnosis. Multicenter AIDS Cohort Study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 2 (1996) 309-316
44. Stark D., and Vedres B. Social times of network spaces: network sequences and foreign investment in Hungary. American Journal of Sociology 111 (2006) 1367-1411
45. Stinchombe A.L. Information and Organizations (1990), University of California Press, Berkeley
46. In: Stoneman P. (Ed). Handbook of the Economics of Innovation and Technological Change (1995), Blackwell, Cambridge
47. Torre D., and Tambini R. Antiretroviral drug resistance testing in patients with HIV-1 infection: a meta-analysis study. HIV Clinical Trials 3 (2002) 1-8
48. U.S. Department of Health and Human Services, 1998-2006. Guidelines for the use of antiretroviral agents in HIV infected adults and adolescents. Archived Guidelines. Available at: http://www.aidsinfo.nih.gov/guidelines/archive.asp.
49. van den Bulte C., and Lilien G.L. Medical innovation revisited: social contagion versus marketing effort. American Journal of Sociology 106 (2001) 1409-1435
50. Vincenti W. What Engineers Know and How They Know It (1991), Cambridge University Press
51. Wu L.L. Some comments on sequence analysis and optimal matching methods in sociology: review and prospect. Sociological Methods and Research 29 (2000) 41-64
52. In: Ziman J. (Ed). Technological Innovation as an Evolutionary Process (2000), Cambridge University Press